XLT Biopharmaceuticals Ltd. Signs $108M Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
3/20/2008 6:22:29 AM
More...
|
XLT Biopharmaceuticals Ltd. Announces Delisting From the Official List of the United Kingdom Listing Authority Processing
10/31/2007 8:42:07 AM
More...
|
XLT Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
9/25/2007 12:32:01 PM
More...
|
XLT Biopharmaceuticals Ltd. to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
9/11/2007 10:46:27 AM
More...
|
XLT Biopharmaceuticals Ltd. Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
9/10/2007 8:32:56 AM
More...
|
XLT Biopharmaceuticals Ltd. to Present at the Arch Investment Conference
9/5/2007 10:02:41 AM
More...
|
XLT Biopharmaceuticals Ltd. Annual General Meeting
8/15/2007 11:29:01 AM
More...
|
The Day In Review: Sanofi-Aventis (France) (SASY.PA) Loses Lovenox Patent
2/9/2007 5:04:04 PM
More...
|
XLT Biopharmaceuticals Ltd. Notice Of AGM
9/26/2006 12:47:00 PM
More...
|
XLT Biopharmaceuticals Ltd. Announces Financial Results For The Six Months Ended June 30, 2006
8/15/2006 10:16:30 AM
More...
|
|